Cardiac Physiology and Pathology

The Cardiac Physiology and Pathology group is formed by researchers with a strong clinical background. The principal investigator is Dr. Fernando Worner.

The group has participated in relevant clinical trials in cardiovascular disease and in multiple nationwide multicenter registries, which has allowed it to become part of a network of centers with interest in cardiovascular research.

The objectives of the group in the coming years are, in addition to consolidating its clinical research base, the progressive development of translational projects that link clinical and basic research, as well as the development of animal models. Among our lines of development are, a) the study of coronary microvascular dysfunction in patients with angina, b) the search for strategies to reduce reperfusion injury and microvascular obstruction in patients with myocardial infarction, c) the analysis of advanced cardiac imaging parameters and biochemical markers involved in the evolution of atrial fibrillation, d) the study of entities related to myocardial infarction with no obstructive coronary arteries (MINOCA), such as myocarditis or spontaneous coronary artery dissection, and the study of cardiac involvement by COVID-19.